Bellus reports 3Q loss

11/08/17 09:41 AM EST

LAVAL, Quebec (AP) _ Bellus Health Inc. (BLUSF) on Wednesday reported a loss of $1.3 million in its third quarter.

On a per-share basis, the Laval, Quebec-based company said it had a loss of 2 cents.

The drug developer posted revenue of $74,200 in the period. Its adjusted revenue was $74,000.

The company's shares closed at 32 cents. A year ago, they were trading at 20 cents.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on BLUSF at